Hygieia

Chinese biotechs continued to secure smaller-sized fundings backed by venture capital and private equity firms in September and October, with the single largest fundraising standing at $42m. Shanghai-

Chinese developers of radionuclide-based therapies snapped up sizable fundraising deals in March, backed by venture capital (VC) and private equity (PE) funds, while innovative vaccines and cell/gene

Company Changes ALATARIS , Kostantinos, PhD To: Zosano Pharma Corp. , Pres. & COO (September) From: IRRAS AB, Exec. Chairman Phone: 510-745-1200 BARTH , Neil M., MD To: Veracyte Inc. , CMO

New At The Helm Company Changes ABUSHAKRA , Susan, MD To: Alzheon Inc. , CMO (September) From: Transition Therapeutics Inc., CMO Phone: 857-214-7242 ALATARIS , Kostantinos, PhD To: Zosano P